Tocilizumab in Chronic Inflammatory CPPD Disease

Clinical trial NCT07254637 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07254637
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Calcium Pyrophosphate Deposition Disease

Start date: 2026-04-01
Primary completion: 2026-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.